{
    "cells": [
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "# Clinical Trial Navigator\n\nThe purpose of of this program is to query the ClinicalTrials.gov database and return a formatted database file of clinical trials based on custom search criteria.\n\nThe database file will contain details around clinical trial design, protocol, indication, product, start/completion date, and outcome measures.\n\nThis database file will be used to conduct detailed analyses, i.e. to compare duration, trial sample size, endpoints used, and outcome performance for all phase 3 trials in a specific indication or in a specific drug class."
        },
        {
            "cell_type": "code",
            "execution_count": 280,
            "metadata": {},
            "outputs": [],
            "source": "import pandas as pd\nimport numpy as np\nimport matplotlib.pyplot as plt\nimport seaborn as sns\nimport requests\nimport json\nfrom pandas.io.json import json_normalize # tranform JSON file into a pandas dataframe\nimport time\n    \npd.set_option('display.max_columns', None)\npd.set_option('display.max_rows', None)"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "I used an object-oriented approach to design this Clinical Trial Navigator tool.  \n\nI designed a Query class to draft the query that will be used to search the ClinicalTrials.gov API.  I pre-selected a list of field names I found to be of greatest interest (the API allows up to 25 field values per query), and the full list of field names can be found at https://clinicaltrials.gov/api/info/study_structure. The Query class also converts the JSON query result to a pandas dataframe, an easier format with which to perform analyses.\n\nThe Study class below represents individual clinical studies, and will be used to extract the various clinical trial criteria from the individual studies to allow for detailed analyses."
        },
        {
            "cell_type": "code",
            "execution_count": 224,
            "metadata": {},
            "outputs": [],
            "source": "class Query:        # class to create a query from the clinicaltrials API that will house the list of clinical trials returned from the API, with detailed information for each\n    \n    def __init__(self, name = 'Query_1'):\n        self.name = name\n        self.study_tracker = []\n\n    def build_query(self):\n        query_terms = input('Enter the search query term: \\n')\n        query_tokenized = query_terms.split()\n        \n        field_values = ['NCTId', 'BriefTitle', 'Condition', 'Phase', 'StudyType',\n                        'EnrollmentCount', 'StartDate', 'PrimaryCompletionDate', 'EligibilityCriteria', 'InterventionName', \n                        'ArmGroupInterventionName', 'ArmGroupDescription', 'InterventionArmGroupLabel', 'OutcomeMeasureType', 'OutcomeMeasureTitle',\n                        'OutcomeMeasureDescription', 'OutcomeMeasureTimeFrame', 'OutcomeMeasurementValue', 'OutcomeMeasureUnitOfMeasure']\n        \n        max_rank = 1000\n        \n        \n        url = 'https://clinicaltrials.gov/api/query/study_fields?expr='\n        \n        for i, word in enumerate(query_tokenized):\n            if i is 0:\n                url = url + word\n            else:\n                url = url + '+' + word\n            \n        url = url + '&fields='\n        \n        for i, word in enumerate(field_values):\n            if i is 0:\n                url = url + word\n            else:\n                url = url + '%2C' + word\n        \n        url = url + '&min_rnk=1&max_rnk=' + str(max_rank) + '&fmt=json'\n        url = url.strip()\n        self.url = url\n        \n        print('Querying 1,000 trials from clinicaltrials.gov with the following url...\\n\\n'+url)\n        \n    def build_study_table(self, url):\n          \n        ## convert the query result to pandas dataframe\n        \n        result = requests.get(url).json()\n        result_list = [result for result in result['StudyFieldsResponse']['StudyFields'] if result['OutcomeMeasureType']]     #loop through the list and identify ONLY studies with outcome measures reported \n        df_master = json_normalize(result_list[0])      # initialize dataframe using JSON result\n\n        try:\n            for study in result_list[1:]:        # concatenate each study to the dataframe to generate master dataframe\n                df = json_normalize(study)\n                df_master = pd.concat([df_master, df], axis=0, ignore_index=True)\n        except:\n            pass\n        \n        df_master['NCTId'] = [df_master['NCTId'][i][0] for i in range(len(df_master['NCTId']))]\n        df_master['BriefTitle'] = [df_master['BriefTitle'][i][0] for i in range(len(df_master['BriefTitle']))]\n        df_master['Condition'] = [df_master['Condition'][i][0] for i in range(len(df_master['Condition']))]\n        df_master['StudyType'] = [df_master['StudyType'][i][0] for i in range(len(df_master['StudyType']))]\n        df_master['Phase'] = [df_master['Phase'][i][0] for i in range(len(df_master['Phase']))]\n        df_master['EnrollmentCount'] = [df_master['EnrollmentCount'][i][0] for i in range(len(df_master['EnrollmentCount']))]\n        df_master['StartDate'] = [df_master['StartDate'][i][0] for i in range(len(df_master['StartDate']))]\n        df_master['PrimaryCompletionDate'] = [df_master['PrimaryCompletionDate'][i][0] for i in range(len(df_master['PrimaryCompletionDate']))]\n        df_master['EligibilityCriteria'] = [df_master['EligibilityCriteria'][i][0] for i in range(len(df_master['EligibilityCriteria']))]\n        \n        #df_master['StartDate'] = pd.to_datetime(df_master['StartDate'])\n        #df_master['PrimaryCompletionDate'] = pd.to_datetime(df_master['PrimaryCompletionDate'])\n        \n        self.df_master = df_master\n        \n        return self.df_master\n    \n    def get_url(self):\n        return self.url\n\n    def get_study_tracker(self):\n        return self.study_tracker\n    \n    def get_df_master(self):\n        return self.df_master\n        "
        },
        {
            "cell_type": "code",
            "execution_count": 318,
            "metadata": {},
            "outputs": [],
            "source": "class Study:\n    \n    def __init__(self, query, nct_id):\n        \n        self.nct_id = nct_id\n        self.entry = query.get_df_master()[query.get_df_master()['NCTId']==nct_id]\n        self.df_outcomes = pd.DataFrame(columns=self.entry.columns)\n        \n        try:\n            self.measures_per_outcome = len(self.entry['OutcomeMeasurementValue'][0])//len(self.entry['OutcomeMeasureTitle'][0])\n        except:\n            self.measures_per_outcome = 1\n        \n        if self.nct_id not in query.study_tracker:\n            query.study_tracker.append(self.nct_id)\n        \n    def get_entry(self):\n        return self.entry\n    \n    def get_indication(self):\n        return [item for item in self.entry['Condition']][0]     # returns the first list item within the list of target\n\n    def extract_outcomes(self):            #iterate thru all outcome measures, create a dataframe with all required info\n        \n        try:\n            self.df_outcomes = self.df_outcomes.drop(columns=['Rank', 'Condition','BriefTitle', 'Phase', 'StudyType', \n                                                          'EnrollmentCount', 'StartDate', 'PrimaryCompletionDate', 'EligibilityCriteria', \n                                                          'InterventionName', 'ArmGroupInterventionName', 'ArmGroupDescription', 'InterventionArmGroupLabel'])\n        except:\n            pass\n        \n        for i, item in enumerate(self.entry['OutcomeMeasureType']):\n                \n            try:\n                self.df_outcomes['OutcomeMeasureType'] = [item for item in self.entry['OutcomeMeasureType']][0]\n            except:\n                pass\n            try:\n                self.df_outcomes['OutcomeMeasureTitle'] = [item for item in self.entry['OutcomeMeasureTitle']][0]\n            except:\n                pass\n            try:\n                self.df_outcomes['OutcomeMeasureDescription'] = [item for item in self.entry['OutcomeMeasureDescription']][0]\n            except:\n                pass\n            try:\n                self.df_outcomes['OutcomeMeasureTimeFrame'] = [item for item in self.entry['OutcomeMeasureTimeFrame']][0]\n            except:\n                pass\n            \n            try:\n                self.df_outcomes['OutcomeMeasureUnitOfMeasure'] = [item for item in self.entry['OutcomeMeasureUnitOfMeasure']][0]\n            except:\n                pass\n\n                                        # maps correct number of outcome measures reported in the study\n        beginning = 0\n        increment = self.measures_per_outcome\n       \n        \n        for i in range(len(self.df_outcomes)):\n            try:\n                self.df_outcomes['OutcomeMeasurementValue'][i] = self.entry['OutcomeMeasurementValue'][0][beginning:beginning+increment]\n                beginning += increment\n            except:\n                pass\n        \n        self.df_outcomes['NCTId'] = [item for item in self.entry['NCTId']][0]\n        \n        return self.df_outcomes"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "I will now instantiate a new query for severe atopic dermatitis, or eczema, an inflammatory condition of the skin."
        },
        {
            "cell_type": "code",
            "execution_count": 356,
            "metadata": {},
            "outputs": [
                {
                    "name": "stdout",
                    "output_type": "stream",
                    "text": "Enter the search query term: \nsevere atopic dermatitis\nQuerying 1,000 trials from clinicaltrials.gov with the following url...\n\nhttps://clinicaltrials.gov/api/query/study_fields?expr=severe+atopic+dermatitis&fields=NCTId%2CBriefTitle%2CCondition%2CPhase%2CStudyType%2CEnrollmentCount%2CStartDate%2CPrimaryCompletionDate%2CEligibilityCriteria%2CInterventionName%2CArmGroupInterventionName%2CArmGroupDescription%2CInterventionArmGroupLabel%2COutcomeMeasureType%2COutcomeMeasureTitle%2COutcomeMeasureDescription%2COutcomeMeasureTimeFrame%2COutcomeMeasurementValue%2COutcomeMeasureUnitOfMeasure&min_rnk=1&max_rnk=1000&fmt=json\n"
                }
            ],
            "source": "atopic_derm = Query()\natopic_derm.build_query()"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "I see my query URL built using my Query class' build_query function.  Let's take a look at the clinical trials returned from this request."
        },
        {
            "cell_type": "code",
            "execution_count": 359,
            "metadata": {},
            "outputs": [
                {
                    "name": "stderr",
                    "output_type": "stream",
                    "text": "/opt/conda/envs/Python-3.7-main/lib/python3.7/site-packages/ipykernel/__main__.py:51: FutureWarning: pandas.io.json.json_normalize is deprecated, use pandas.json_normalize instead\n/opt/conda/envs/Python-3.7-main/lib/python3.7/site-packages/ipykernel/__main__.py:55: FutureWarning: pandas.io.json.json_normalize is deprecated, use pandas.json_normalize instead\n"
                },
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>NCTId</th>\n      <th>BriefTitle</th>\n      <th>Condition</th>\n      <th>Phase</th>\n      <th>StudyType</th>\n      <th>EnrollmentCount</th>\n      <th>StartDate</th>\n      <th>PrimaryCompletionDate</th>\n      <th>EligibilityCriteria</th>\n      <th>InterventionName</th>\n      <th>ArmGroupInterventionName</th>\n      <th>ArmGroupDescription</th>\n      <th>InterventionArmGroupLabel</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>12</td>\n      <td>NCT03054428</td>\n      <td>Efficacy and Safety of Dupilumab in Participan...</td>\n      <td>Moderate-to-Severe Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>251</td>\n      <td>March 21, 2017</td>\n      <td>April 4, 2018</td>\n      <td>Inclusion Criteria:\\n\\nMale or female \u226512 to &lt;...</td>\n      <td>[Dupilumab, Placebo]</td>\n      <td>[Drug: Placebo, Drug: Dupilumab, Drug: Dupilumab]</td>\n      <td>[Participants received placebo matching dupilu...</td>\n      <td>[Dupilumab 200 mg or 300 mg Q2W, Dupilumab 300...</td>\n      <td>[Primary, Primary, Secondary, Secondary, Secon...</td>\n      <td>[Percentage of Participants With Investigator'...</td>\n      <td>[IGA is an assessment scale used to determine ...</td>\n      <td>[Baseline and Week 16, Baseline and Week 16, B...</td>\n      <td>[2.4, 17.9, 24.4, 8.2, 38.1, 41.5, -23.6, -64....</td>\n      <td>[Percentage of participants, Percentage of par...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>13</td>\n      <td>NCT03831191</td>\n      <td>A Study of LY3375880 in Adults With Moderate-t...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 2</td>\n      <td>Interventional</td>\n      <td>136</td>\n      <td>February 12, 2019</td>\n      <td>February 27, 2020</td>\n      <td>Inclusion Criteria:\\n\\nParticipants must have ...</td>\n      <td>[LY3375880, Placebo]</td>\n      <td>[Drug: LY3375880, Drug: LY3375880, Drug: LY337...</td>\n      <td>[Induction Period:\\n\\nParticipants received 50...</td>\n      <td>[150 mg LY3375880, 50 mg LY3375880, 600 mg LY3...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percentage of Participants Achieving Validate...</td>\n      <td>[vIGA-AD measures participants' overall severi...</td>\n      <td>[Week 16, Week 16, Week 16, Week 16, Baseline,...</td>\n      <td>[9.5, 5.0, 5.9, 4.8, 19.0, 15.0, 23.5, 0.0, 4....</td>\n      <td>[Percentage of participants, Percentage of Par...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>14</td>\n      <td>NCT03334422</td>\n      <td>Study of Baricitinib (LY3009104) in Patients W...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>615</td>\n      <td>November 27, 2017</td>\n      <td>December 12, 2018</td>\n      <td>Inclusion Criteria:\\n\\nHave been diagnosed wit...</td>\n      <td>[Baricitinib, Placebo]</td>\n      <td>[Drug: Baricitinib, Drug: Placebo, Drug: Baric...</td>\n      <td>[4mg Baricitinib administered orally once dail...</td>\n      <td>[1mg Baricitinib, 2mg Baricitinib, 4 Milligram...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percentage of Participants Achieving Investig...</td>\n      <td>[The IGA measures the investigator's global as...</td>\n      <td>[16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...</td>\n      <td>[4.5, 10.6, 13.8, 4.5, 8.8, 6.1, 12.8, 17.9, 2...</td>\n      <td>[percentage of participants, percentage of par...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>15</td>\n      <td>NCT01785602</td>\n      <td>Efficacy and Safety Study of QAW039 in the Tre...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 2</td>\n      <td>Interventional</td>\n      <td>103</td>\n      <td>June 2013</td>\n      <td>November 2014</td>\n      <td>Key Inclusion Criteria:\\n\\nPresence of atopic ...</td>\n      <td>[QAW039, Placebo]</td>\n      <td>[Drug: QAW039, Drug: Placebo]</td>\n      <td>[Participants received QAW039 450 mg daily by ...</td>\n      <td>[QAW039, Placebo]</td>\n      <td>[Primary, Secondary]</td>\n      <td>[Change From Baseline in Eczema Area and Sever...</td>\n      <td>[Investigators assessed presence and severity ...</td>\n      <td>[Baseline, 12 weeks, Baseline, 4 weeks, 8 weeks]</td>\n      <td>[-8.65, -6.95, -6.22, -5.89, -7.49, -5.61]</td>\n      <td>[Score on a scale, Score on a scale]</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>16</td>\n      <td>NCT03443024</td>\n      <td>A Study of Lebrikizumab (LY3650150) in Partici...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 2</td>\n      <td>Interventional</td>\n      <td>280</td>\n      <td>January 30, 2018</td>\n      <td>February 7, 2019</td>\n      <td>Inclusion Criteria:\\n\\nMale or female, 18 year...</td>\n      <td>[Lebrikizumab, Placebo]</td>\n      <td>[Biological: Lebrikizumab, Drug: Placebo, Biol...</td>\n      <td>[125 mg Lebrikizumab administered subcutaneous...</td>\n      <td>[125 milligrams (mg) Lebrikizumab - Every 4 We...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percent Change From Baseline in Eczema Area a...</td>\n      <td>[The EASI assesses objective physician estimat...</td>\n      <td>[Baseline, Week 16, Week 16, Week 16, Week 16,...</td>\n      <td>[-62.34, -69.21, -72.09, -41.12, 43.3, 56.1, 6...</td>\n      <td>[percent change, percentage of participants, p...</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "   Rank        NCTId                                         BriefTitle  \\\n0    12  NCT03054428  Efficacy and Safety of Dupilumab in Participan...   \n1    13  NCT03831191  A Study of LY3375880 in Adults With Moderate-t...   \n2    14  NCT03334422  Study of Baricitinib (LY3009104) in Patients W...   \n3    15  NCT01785602  Efficacy and Safety Study of QAW039 in the Tre...   \n4    16  NCT03443024  A Study of Lebrikizumab (LY3650150) in Partici...   \n\n                              Condition    Phase       StudyType  \\\n0  Moderate-to-Severe Atopic Dermatitis  Phase 3  Interventional   \n1                     Atopic Dermatitis  Phase 2  Interventional   \n2                     Atopic Dermatitis  Phase 3  Interventional   \n3                     Atopic Dermatitis  Phase 2  Interventional   \n4                     Atopic Dermatitis  Phase 2  Interventional   \n\n  EnrollmentCount          StartDate PrimaryCompletionDate  \\\n0             251     March 21, 2017         April 4, 2018   \n1             136  February 12, 2019     February 27, 2020   \n2             615  November 27, 2017     December 12, 2018   \n3             103          June 2013         November 2014   \n4             280   January 30, 2018      February 7, 2019   \n\n                                 EligibilityCriteria         InterventionName  \\\n0  Inclusion Criteria:\\n\\nMale or female \u226512 to <...     [Dupilumab, Placebo]   \n1  Inclusion Criteria:\\n\\nParticipants must have ...     [LY3375880, Placebo]   \n2  Inclusion Criteria:\\n\\nHave been diagnosed wit...   [Baricitinib, Placebo]   \n3  Key Inclusion Criteria:\\n\\nPresence of atopic ...        [QAW039, Placebo]   \n4  Inclusion Criteria:\\n\\nMale or female, 18 year...  [Lebrikizumab, Placebo]   \n\n                            ArmGroupInterventionName  \\\n0  [Drug: Placebo, Drug: Dupilumab, Drug: Dupilumab]   \n1  [Drug: LY3375880, Drug: LY3375880, Drug: LY337...   \n2  [Drug: Baricitinib, Drug: Placebo, Drug: Baric...   \n3                      [Drug: QAW039, Drug: Placebo]   \n4  [Biological: Lebrikizumab, Drug: Placebo, Biol...   \n\n                                 ArmGroupDescription  \\\n0  [Participants received placebo matching dupilu...   \n1  [Induction Period:\\n\\nParticipants received 50...   \n2  [4mg Baricitinib administered orally once dail...   \n3  [Participants received QAW039 450 mg daily by ...   \n4  [125 mg Lebrikizumab administered subcutaneous...   \n\n                           InterventionArmGroupLabel  \\\n0  [Dupilumab 200 mg or 300 mg Q2W, Dupilumab 300...   \n1  [150 mg LY3375880, 50 mg LY3375880, 600 mg LY3...   \n2  [1mg Baricitinib, 2mg Baricitinib, 4 Milligram...   \n3                                  [QAW039, Placebo]   \n4  [125 milligrams (mg) Lebrikizumab - Every 4 We...   \n\n                                  OutcomeMeasureType  \\\n0  [Primary, Primary, Secondary, Secondary, Secon...   \n1  [Primary, Secondary, Secondary, Secondary, Sec...   \n2  [Primary, Secondary, Secondary, Secondary, Sec...   \n3                               [Primary, Secondary]   \n4  [Primary, Secondary, Secondary, Secondary, Sec...   \n\n                                 OutcomeMeasureTitle  \\\n0  [Percentage of Participants With Investigator'...   \n1  [Percentage of Participants Achieving Validate...   \n2  [Percentage of Participants Achieving Investig...   \n3  [Change From Baseline in Eczema Area and Sever...   \n4  [Percent Change From Baseline in Eczema Area a...   \n\n                           OutcomeMeasureDescription  \\\n0  [IGA is an assessment scale used to determine ...   \n1  [vIGA-AD measures participants' overall severi...   \n2  [The IGA measures the investigator's global as...   \n3  [Investigators assessed presence and severity ...   \n4  [The EASI assesses objective physician estimat...   \n\n                             OutcomeMeasureTimeFrame  \\\n0  [Baseline and Week 16, Baseline and Week 16, B...   \n1  [Week 16, Week 16, Week 16, Week 16, Baseline,...   \n2  [16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...   \n3   [Baseline, 12 weeks, Baseline, 4 weeks, 8 weeks]   \n4  [Baseline, Week 16, Week 16, Week 16, Week 16,...   \n\n                             OutcomeMeasurementValue  \\\n0  [2.4, 17.9, 24.4, 8.2, 38.1, 41.5, -23.6, -64....   \n1  [9.5, 5.0, 5.9, 4.8, 19.0, 15.0, 23.5, 0.0, 4....   \n2  [4.5, 10.6, 13.8, 4.5, 8.8, 6.1, 12.8, 17.9, 2...   \n3         [-8.65, -6.95, -6.22, -5.89, -7.49, -5.61]   \n4  [-62.34, -69.21, -72.09, -41.12, 43.3, 56.1, 6...   \n\n                         OutcomeMeasureUnitOfMeasure  \n0  [Percentage of participants, Percentage of par...  \n1  [Percentage of participants, Percentage of Par...  \n2  [percentage of participants, percentage of par...  \n3               [Score on a scale, Score on a scale]  \n4  [percent change, percentage of participants, p...  "
                    },
                    "execution_count": 359,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "atopic_derm_table = atopic_derm.build_study_table(atopic_derm.get_url())\natopic_derm_table.head()"
        },
        {
            "cell_type": "code",
            "execution_count": 360,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/plain": "(112, 20)"
                    },
                    "execution_count": 360,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "atopic_derm_table.shape"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "There are 112 clinical trials returned from our query.  (NOTE: my query is ONLY returning studies that have outcome measures reported on ClinicalTrials.gov).  I will narrow this down a bit more to only Phase 3 trials, which represent the pivotal trial."
        },
        {
            "cell_type": "code",
            "execution_count": 361,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>NCTId</th>\n      <th>BriefTitle</th>\n      <th>Condition</th>\n      <th>Phase</th>\n      <th>StudyType</th>\n      <th>EnrollmentCount</th>\n      <th>StartDate</th>\n      <th>PrimaryCompletionDate</th>\n      <th>EligibilityCriteria</th>\n      <th>InterventionName</th>\n      <th>ArmGroupInterventionName</th>\n      <th>ArmGroupDescription</th>\n      <th>InterventionArmGroupLabel</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>12</td>\n      <td>NCT03054428</td>\n      <td>Efficacy and Safety of Dupilumab in Participan...</td>\n      <td>Moderate-to-Severe Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>251</td>\n      <td>March 21, 2017</td>\n      <td>April 4, 2018</td>\n      <td>Inclusion Criteria:\\n\\nMale or female \u226512 to &lt;...</td>\n      <td>[Dupilumab, Placebo]</td>\n      <td>[Drug: Placebo, Drug: Dupilumab, Drug: Dupilumab]</td>\n      <td>[Participants received placebo matching dupilu...</td>\n      <td>[Dupilumab 200 mg or 300 mg Q2W, Dupilumab 300...</td>\n      <td>[Primary, Primary, Secondary, Secondary, Secon...</td>\n      <td>[Percentage of Participants With Investigator'...</td>\n      <td>[IGA is an assessment scale used to determine ...</td>\n      <td>[Baseline and Week 16, Baseline and Week 16, B...</td>\n      <td>[2.4, 17.9, 24.4, 8.2, 38.1, 41.5, -23.6, -64....</td>\n      <td>[Percentage of participants, Percentage of par...</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>14</td>\n      <td>NCT03334422</td>\n      <td>Study of Baricitinib (LY3009104) in Patients W...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>615</td>\n      <td>November 27, 2017</td>\n      <td>December 12, 2018</td>\n      <td>Inclusion Criteria:\\n\\nHave been diagnosed wit...</td>\n      <td>[Baricitinib, Placebo]</td>\n      <td>[Drug: Baricitinib, Drug: Placebo, Drug: Baric...</td>\n      <td>[4mg Baricitinib administered orally once dail...</td>\n      <td>[1mg Baricitinib, 2mg Baricitinib, 4 Milligram...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percentage of Participants Achieving Investig...</td>\n      <td>[The IGA measures the investigator's global as...</td>\n      <td>[16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...</td>\n      <td>[4.5, 10.6, 13.8, 4.5, 8.8, 6.1, 12.8, 17.9, 2...</td>\n      <td>[percentage of participants, percentage of par...</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>19</td>\n      <td>NCT03334396</td>\n      <td>A Study of Baricitinib (LY3009104) in Patients...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>660</td>\n      <td>November 23, 2017</td>\n      <td>December 6, 2018</td>\n      <td>Inclusion Criteria:\\n\\nHave been diagnosed wit...</td>\n      <td>[Baricitinib, Placebo]</td>\n      <td>[Drug: Baricitinib, Drug: Placebo, Drug: Baric...</td>\n      <td>[4 mg Baricitinib administered orally once dai...</td>\n      <td>[1 mg Baricitinib, 1 mg Baricitinib Maximum Ex...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percentage of Participants Achieving Investig...</td>\n      <td>[The IGA measures the investigator's global as...</td>\n      <td>[16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...</td>\n      <td>[4.8, 11.4, 16.8, 4.8, 11.8, 8.8, 17.3, 18.7, ...</td>\n      <td>[percentage of participants, percentage of par...</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>20</td>\n      <td>NCT03435081</td>\n      <td>A Study of Baricitinib (LY3009104) in Adult Pa...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>440</td>\n      <td>February 20, 2018</td>\n      <td>December 9, 2019</td>\n      <td>Inclusion Criteria:\\n\\nHave a diagnosis of ato...</td>\n      <td>[Baricitinib, Placebo]</td>\n      <td>[Drug: Baricitinib, Drug: Placebo, Drug: Baric...</td>\n      <td>[2 mg Baricitinib administered orally every da...</td>\n      <td>[1 mg Baricitinib, 2 milligram (mg) Baricitini...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percentage of Participants Achieving Eczema A...</td>\n      <td>[The EASI assesses objective physician estimat...</td>\n      <td>[Week 16, Week 16, Week 16, Week 16, Baseline,...</td>\n      <td>[8.2, 29.5, 5.4, 12.9, 24.0, 8.2, 12.9, 3.4, 7...</td>\n      <td>[percentage of participants, percentage of par...</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>36</td>\n      <td>NCT03733301</td>\n      <td>A Study of Baricitinib (LY3009104) in Combinat...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>329</td>\n      <td>November 16, 2018</td>\n      <td>July 29, 2019</td>\n      <td>Inclusion Criteria:\\n\\nHave been diagnosed wit...</td>\n      <td>[Baricitinib, Topical corticosteroid, Placebo]</td>\n      <td>[Drug: Baricitinib, Drug: Topical corticostero...</td>\n      <td>[4 mg Baricitinib administered orally once dai...</td>\n      <td>[2 mg Baricitinib, 4 Milligram (mg) Baricitini...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percentage of Participants Achieving Investig...</td>\n      <td>[The IGA measures investigators global assessm...</td>\n      <td>[Week 16, Week 16, Week 16, Baseline, Week 16,...</td>\n      <td>[14.7, 23.9, 30.6, 22.9, 43.1, 47.7, 13.8, 16....</td>\n      <td>[percentage of participants, percentage of par...</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "   Rank        NCTId                                         BriefTitle  \\\n0    12  NCT03054428  Efficacy and Safety of Dupilumab in Participan...   \n1    14  NCT03334422  Study of Baricitinib (LY3009104) in Patients W...   \n2    19  NCT03334396  A Study of Baricitinib (LY3009104) in Patients...   \n3    20  NCT03435081  A Study of Baricitinib (LY3009104) in Adult Pa...   \n4    36  NCT03733301  A Study of Baricitinib (LY3009104) in Combinat...   \n\n                              Condition    Phase       StudyType  \\\n0  Moderate-to-Severe Atopic Dermatitis  Phase 3  Interventional   \n1                     Atopic Dermatitis  Phase 3  Interventional   \n2                     Atopic Dermatitis  Phase 3  Interventional   \n3                     Atopic Dermatitis  Phase 3  Interventional   \n4                     Atopic Dermatitis  Phase 3  Interventional   \n\n  EnrollmentCount          StartDate PrimaryCompletionDate  \\\n0             251     March 21, 2017         April 4, 2018   \n1             615  November 27, 2017     December 12, 2018   \n2             660  November 23, 2017      December 6, 2018   \n3             440  February 20, 2018      December 9, 2019   \n4             329  November 16, 2018         July 29, 2019   \n\n                                 EligibilityCriteria  \\\n0  Inclusion Criteria:\\n\\nMale or female \u226512 to <...   \n1  Inclusion Criteria:\\n\\nHave been diagnosed wit...   \n2  Inclusion Criteria:\\n\\nHave been diagnosed wit...   \n3  Inclusion Criteria:\\n\\nHave a diagnosis of ato...   \n4  Inclusion Criteria:\\n\\nHave been diagnosed wit...   \n\n                                 InterventionName  \\\n0                            [Dupilumab, Placebo]   \n1                          [Baricitinib, Placebo]   \n2                          [Baricitinib, Placebo]   \n3                          [Baricitinib, Placebo]   \n4  [Baricitinib, Topical corticosteroid, Placebo]   \n\n                            ArmGroupInterventionName  \\\n0  [Drug: Placebo, Drug: Dupilumab, Drug: Dupilumab]   \n1  [Drug: Baricitinib, Drug: Placebo, Drug: Baric...   \n2  [Drug: Baricitinib, Drug: Placebo, Drug: Baric...   \n3  [Drug: Baricitinib, Drug: Placebo, Drug: Baric...   \n4  [Drug: Baricitinib, Drug: Topical corticostero...   \n\n                                 ArmGroupDescription  \\\n0  [Participants received placebo matching dupilu...   \n1  [4mg Baricitinib administered orally once dail...   \n2  [4 mg Baricitinib administered orally once dai...   \n3  [2 mg Baricitinib administered orally every da...   \n4  [4 mg Baricitinib administered orally once dai...   \n\n                           InterventionArmGroupLabel  \\\n0  [Dupilumab 200 mg or 300 mg Q2W, Dupilumab 300...   \n1  [1mg Baricitinib, 2mg Baricitinib, 4 Milligram...   \n2  [1 mg Baricitinib, 1 mg Baricitinib Maximum Ex...   \n3  [1 mg Baricitinib, 2 milligram (mg) Baricitini...   \n4  [2 mg Baricitinib, 4 Milligram (mg) Baricitini...   \n\n                                  OutcomeMeasureType  \\\n0  [Primary, Primary, Secondary, Secondary, Secon...   \n1  [Primary, Secondary, Secondary, Secondary, Sec...   \n2  [Primary, Secondary, Secondary, Secondary, Sec...   \n3  [Primary, Secondary, Secondary, Secondary, Sec...   \n4  [Primary, Secondary, Secondary, Secondary, Sec...   \n\n                                 OutcomeMeasureTitle  \\\n0  [Percentage of Participants With Investigator'...   \n1  [Percentage of Participants Achieving Investig...   \n2  [Percentage of Participants Achieving Investig...   \n3  [Percentage of Participants Achieving Eczema A...   \n4  [Percentage of Participants Achieving Investig...   \n\n                           OutcomeMeasureDescription  \\\n0  [IGA is an assessment scale used to determine ...   \n1  [The IGA measures the investigator's global as...   \n2  [The IGA measures the investigator's global as...   \n3  [The EASI assesses objective physician estimat...   \n4  [The IGA measures investigators global assessm...   \n\n                             OutcomeMeasureTimeFrame  \\\n0  [Baseline and Week 16, Baseline and Week 16, B...   \n1  [16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...   \n2  [16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...   \n3  [Week 16, Week 16, Week 16, Week 16, Baseline,...   \n4  [Week 16, Week 16, Week 16, Baseline, Week 16,...   \n\n                             OutcomeMeasurementValue  \\\n0  [2.4, 17.9, 24.4, 8.2, 38.1, 41.5, -23.6, -64....   \n1  [4.5, 10.6, 13.8, 4.5, 8.8, 6.1, 12.8, 17.9, 2...   \n2  [4.8, 11.4, 16.8, 4.8, 11.8, 8.8, 17.3, 18.7, ...   \n3  [8.2, 29.5, 5.4, 12.9, 24.0, 8.2, 12.9, 3.4, 7...   \n4  [14.7, 23.9, 30.6, 22.9, 43.1, 47.7, 13.8, 16....   \n\n                         OutcomeMeasureUnitOfMeasure  \n0  [Percentage of participants, Percentage of par...  \n1  [percentage of participants, percentage of par...  \n2  [percentage of participants, percentage of par...  \n3  [percentage of participants, percentage of par...  \n4  [percentage of participants, percentage of par...  "
                    },
                    "execution_count": 361,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "# narrow down to only phase 3 trials\n\nad_phase_3 = atopic_derm_table[atopic_derm_table['Phase'].str.lower() == 'phase 3'].reset_index().drop(columns='index')\nad_phase_3.head()"
        },
        {
            "cell_type": "code",
            "execution_count": 362,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/plain": "(31, 20)"
                    },
                    "execution_count": 362,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "ad_phase_3.shape"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "31 studies is a bit more manageable than 112.\n\nI will now instantiate a few Study objects to test the outcome measure extraction functionality.  I will just take the first 3 studies returned in my atopic dermatitis Query."
        },
        {
            "cell_type": "code",
            "execution_count": 364,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>NCTId</th>\n      <th>BriefTitle</th>\n      <th>Condition</th>\n      <th>Phase</th>\n      <th>StudyType</th>\n      <th>EnrollmentCount</th>\n      <th>StartDate</th>\n      <th>PrimaryCompletionDate</th>\n      <th>EligibilityCriteria</th>\n      <th>InterventionName</th>\n      <th>ArmGroupInterventionName</th>\n      <th>ArmGroupDescription</th>\n      <th>InterventionArmGroupLabel</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>12</td>\n      <td>NCT03054428</td>\n      <td>Efficacy and Safety of Dupilumab in Participan...</td>\n      <td>Moderate-to-Severe Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>251</td>\n      <td>March 21, 2017</td>\n      <td>April 4, 2018</td>\n      <td>Inclusion Criteria:\\n\\nMale or female \u226512 to &lt;...</td>\n      <td>[Dupilumab, Placebo]</td>\n      <td>[Drug: Placebo, Drug: Dupilumab, Drug: Dupilumab]</td>\n      <td>[Participants received placebo matching dupilu...</td>\n      <td>[Dupilumab 200 mg or 300 mg Q2W, Dupilumab 300...</td>\n      <td>[Primary, Primary, Secondary, Secondary, Secon...</td>\n      <td>[Percentage of Participants With Investigator'...</td>\n      <td>[IGA is an assessment scale used to determine ...</td>\n      <td>[Baseline and Week 16, Baseline and Week 16, B...</td>\n      <td>[2.4, 17.9, 24.4, 8.2, 38.1, 41.5, -23.6, -64....</td>\n      <td>[Percentage of participants, Percentage of par...</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "   Rank        NCTId                                         BriefTitle  \\\n0    12  NCT03054428  Efficacy and Safety of Dupilumab in Participan...   \n\n                              Condition    Phase       StudyType  \\\n0  Moderate-to-Severe Atopic Dermatitis  Phase 3  Interventional   \n\n  EnrollmentCount       StartDate PrimaryCompletionDate  \\\n0             251  March 21, 2017         April 4, 2018   \n\n                                 EligibilityCriteria      InterventionName  \\\n0  Inclusion Criteria:\\n\\nMale or female \u226512 to <...  [Dupilumab, Placebo]   \n\n                            ArmGroupInterventionName  \\\n0  [Drug: Placebo, Drug: Dupilumab, Drug: Dupilumab]   \n\n                                 ArmGroupDescription  \\\n0  [Participants received placebo matching dupilu...   \n\n                           InterventionArmGroupLabel  \\\n0  [Dupilumab 200 mg or 300 mg Q2W, Dupilumab 300...   \n\n                                  OutcomeMeasureType  \\\n0  [Primary, Primary, Secondary, Secondary, Secon...   \n\n                                 OutcomeMeasureTitle  \\\n0  [Percentage of Participants With Investigator'...   \n\n                           OutcomeMeasureDescription  \\\n0  [IGA is an assessment scale used to determine ...   \n\n                             OutcomeMeasureTimeFrame  \\\n0  [Baseline and Week 16, Baseline and Week 16, B...   \n\n                             OutcomeMeasurementValue  \\\n0  [2.4, 17.9, 24.4, 8.2, 38.1, 41.5, -23.6, -64....   \n\n                         OutcomeMeasureUnitOfMeasure  \n0  [Percentage of participants, Percentage of par...  "
                    },
                    "execution_count": 364,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "study_1 = Study(atopic_derm, ad_phase_3['NCTId'][0])\nstudy_1.get_entry()"
        },
        {
            "cell_type": "code",
            "execution_count": 365,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>NCTId</th>\n      <th>BriefTitle</th>\n      <th>Condition</th>\n      <th>Phase</th>\n      <th>StudyType</th>\n      <th>EnrollmentCount</th>\n      <th>StartDate</th>\n      <th>PrimaryCompletionDate</th>\n      <th>EligibilityCriteria</th>\n      <th>InterventionName</th>\n      <th>ArmGroupInterventionName</th>\n      <th>ArmGroupDescription</th>\n      <th>InterventionArmGroupLabel</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>2</th>\n      <td>14</td>\n      <td>NCT03334422</td>\n      <td>Study of Baricitinib (LY3009104) in Patients W...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>615</td>\n      <td>November 27, 2017</td>\n      <td>December 12, 2018</td>\n      <td>Inclusion Criteria:\\n\\nHave been diagnosed wit...</td>\n      <td>[Baricitinib, Placebo]</td>\n      <td>[Drug: Baricitinib, Drug: Placebo, Drug: Baric...</td>\n      <td>[4mg Baricitinib administered orally once dail...</td>\n      <td>[1mg Baricitinib, 2mg Baricitinib, 4 Milligram...</td>\n      <td>[Primary, Secondary, Secondary, Secondary, Sec...</td>\n      <td>[Percentage of Participants Achieving Investig...</td>\n      <td>[The IGA measures the investigator's global as...</td>\n      <td>[16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...</td>\n      <td>[4.5, 10.6, 13.8, 4.5, 8.8, 6.1, 12.8, 17.9, 2...</td>\n      <td>[percentage of participants, percentage of par...</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "   Rank        NCTId                                         BriefTitle  \\\n2    14  NCT03334422  Study of Baricitinib (LY3009104) in Patients W...   \n\n           Condition    Phase       StudyType EnrollmentCount  \\\n2  Atopic Dermatitis  Phase 3  Interventional             615   \n\n           StartDate PrimaryCompletionDate  \\\n2  November 27, 2017     December 12, 2018   \n\n                                 EligibilityCriteria        InterventionName  \\\n2  Inclusion Criteria:\\n\\nHave been diagnosed wit...  [Baricitinib, Placebo]   \n\n                            ArmGroupInterventionName  \\\n2  [Drug: Baricitinib, Drug: Placebo, Drug: Baric...   \n\n                                 ArmGroupDescription  \\\n2  [4mg Baricitinib administered orally once dail...   \n\n                           InterventionArmGroupLabel  \\\n2  [1mg Baricitinib, 2mg Baricitinib, 4 Milligram...   \n\n                                  OutcomeMeasureType  \\\n2  [Primary, Secondary, Secondary, Secondary, Sec...   \n\n                                 OutcomeMeasureTitle  \\\n2  [Percentage of Participants Achieving Investig...   \n\n                           OutcomeMeasureDescription  \\\n2  [The IGA measures the investigator's global as...   \n\n                             OutcomeMeasureTimeFrame  \\\n2  [16 Weeks, 16 Weeks, 16 Weeks, 16 Weeks, Basel...   \n\n                             OutcomeMeasurementValue  \\\n2  [4.5, 10.6, 13.8, 4.5, 8.8, 6.1, 12.8, 17.9, 2...   \n\n                         OutcomeMeasureUnitOfMeasure  \n2  [percentage of participants, percentage of par...  "
                    },
                    "execution_count": 365,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "study_2 = Study(atopic_derm, ad_phase_3['NCTId'][1])\nstudy_2.get_entry()"
        },
        {
            "cell_type": "code",
            "execution_count": 366,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>Rank</th>\n      <th>NCTId</th>\n      <th>BriefTitle</th>\n      <th>Condition</th>\n      <th>Phase</th>\n      <th>StudyType</th>\n      <th>EnrollmentCount</th>\n      <th>StartDate</th>\n      <th>PrimaryCompletionDate</th>\n      <th>EligibilityCriteria</th>\n      <th>InterventionName</th>\n      <th>ArmGroupInterventionName</th>\n      <th>ArmGroupDescription</th>\n      <th>InterventionArmGroupLabel</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>28</th>\n      <td>91</td>\n      <td>NCT03131648</td>\n      <td>Tralokinumab Monotherapy for Moderate to Sever...</td>\n      <td>Atopic Dermatitis</td>\n      <td>Phase 3</td>\n      <td>Interventional</td>\n      <td>802</td>\n      <td>May 30, 2017</td>\n      <td>August 7, 2018</td>\n      <td>Inclusion Criteria:\\n\\nAge 18 and above\\nDiagn...</td>\n      <td>[Tralokinumab, Placebo]</td>\n      <td>[Drug: Tralokinumab, Drug: Placebo, Drug: Tral...</td>\n      <td>[Week 0 to Week 16:\\n\\nTwo subcutaneous (SC) i...</td>\n      <td>[Initial treatment period - Tralokinumab Q2W, ...</td>\n      <td>[Primary, Primary, Secondary, Secondary, Secon...</td>\n      <td>[Subjects With Investigator's Global Assessmen...</td>\n      <td>[The IGA is an instrument used in clinical tri...</td>\n      <td>[At Week 16, At Week 16, Week 0 to Week 16, We...</td>\n      <td>[95, 14, 150, 25, 119, 20, -25.2, -14.7, -7.1,...</td>\n      <td>[Participants, Participants, Participants, uni...</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "    Rank        NCTId                                         BriefTitle  \\\n28    91  NCT03131648  Tralokinumab Monotherapy for Moderate to Sever...   \n\n            Condition    Phase       StudyType EnrollmentCount     StartDate  \\\n28  Atopic Dermatitis  Phase 3  Interventional             802  May 30, 2017   \n\n   PrimaryCompletionDate                                EligibilityCriteria  \\\n28        August 7, 2018  Inclusion Criteria:\\n\\nAge 18 and above\\nDiagn...   \n\n           InterventionName  \\\n28  [Tralokinumab, Placebo]   \n\n                             ArmGroupInterventionName  \\\n28  [Drug: Tralokinumab, Drug: Placebo, Drug: Tral...   \n\n                                  ArmGroupDescription  \\\n28  [Week 0 to Week 16:\\n\\nTwo subcutaneous (SC) i...   \n\n                            InterventionArmGroupLabel  \\\n28  [Initial treatment period - Tralokinumab Q2W, ...   \n\n                                   OutcomeMeasureType  \\\n28  [Primary, Primary, Secondary, Secondary, Secon...   \n\n                                  OutcomeMeasureTitle  \\\n28  [Subjects With Investigator's Global Assessmen...   \n\n                            OutcomeMeasureDescription  \\\n28  [The IGA is an instrument used in clinical tri...   \n\n                              OutcomeMeasureTimeFrame  \\\n28  [At Week 16, At Week 16, Week 0 to Week 16, We...   \n\n                              OutcomeMeasurementValue  \\\n28  [95, 14, 150, 25, 119, 20, -25.2, -14.7, -7.1,...   \n\n                          OutcomeMeasureUnitOfMeasure  \n28  [Participants, Participants, Participants, uni...  "
                    },
                    "execution_count": 366,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "study_3 = Study(atopic_derm, ad_phase_3['NCTId'][14])\nstudy_3.get_entry()"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "It seems my Study classes are functioning properly so far - let's see if my Query study tracker is capturing the studies created thus far."
        },
        {
            "cell_type": "code",
            "execution_count": 367,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/plain": "['NCT03054428', 'NCT03334422', 'NCT03131648']"
                    },
                    "execution_count": 367,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "atopic_derm.get_study_tracker()"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "So far so good - my studies are being tracked within my atopic_derm query.  Now I want to take a look at the outcome measures reported in the 3 studies I instantiated.\n\nLet's test out the extract_outcomes function to see if I can identify all the different primary and secondary endpoints reporte in each study.  This will come in handy when I compare clinical trials in a later version of this notebook."
        },
        {
            "cell_type": "code",
            "execution_count": 369,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>NCTId</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>NCT03054428</td>\n      <td>Primary</td>\n      <td>Percentage of Participants With Investigator's...</td>\n      <td>IGA is an assessment scale used to determine s...</td>\n      <td>Baseline and Week 16</td>\n      <td>[2.4, 17.9, 24.4]</td>\n      <td>Percentage of participants</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>NCT03054428</td>\n      <td>Primary</td>\n      <td>Percentage of Participants With Eczema Area an...</td>\n      <td>The EASI score was used to measure the severit...</td>\n      <td>Baseline and Week 16</td>\n      <td>[8.2, 38.1, 41.5]</td>\n      <td>Percentage of participants</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>NCT03054428</td>\n      <td>Secondary</td>\n      <td>Percent Change From Baseline in EASI Score at ...</td>\n      <td>The Eczema Area and Severity Index (EASI) scor...</td>\n      <td>Baseline and Week 16</td>\n      <td>[-23.6, -64.8, -65.9]</td>\n      <td>Percent change</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>NCT03054428</td>\n      <td>Secondary</td>\n      <td>Percent Change From Baseline in Weekly Average...</td>\n      <td>Peak Pruritus NRS is an assessment tool used b...</td>\n      <td>Baseline and Week 16</td>\n      <td>[-19.0, -45.5, -47.9]</td>\n      <td>Percent change</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>NCT03054428</td>\n      <td>Secondary</td>\n      <td>Percentage of Participants With Improvement (R...</td>\n      <td>Peak Pruritus NRS is an assessment tool used b...</td>\n      <td>Baseline to Week 16</td>\n      <td>[9.4, 38.6, 48.8]</td>\n      <td>Percentage of participants</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "         NCTId OutcomeMeasureType  \\\n0  NCT03054428            Primary   \n1  NCT03054428            Primary   \n2  NCT03054428          Secondary   \n3  NCT03054428          Secondary   \n4  NCT03054428          Secondary   \n\n                                 OutcomeMeasureTitle  \\\n0  Percentage of Participants With Investigator's...   \n1  Percentage of Participants With Eczema Area an...   \n2  Percent Change From Baseline in EASI Score at ...   \n3  Percent Change From Baseline in Weekly Average...   \n4  Percentage of Participants With Improvement (R...   \n\n                           OutcomeMeasureDescription OutcomeMeasureTimeFrame  \\\n0  IGA is an assessment scale used to determine s...    Baseline and Week 16   \n1  The EASI score was used to measure the severit...    Baseline and Week 16   \n2  The Eczema Area and Severity Index (EASI) scor...    Baseline and Week 16   \n3  Peak Pruritus NRS is an assessment tool used b...    Baseline and Week 16   \n4  Peak Pruritus NRS is an assessment tool used b...     Baseline to Week 16   \n\n  OutcomeMeasurementValue OutcomeMeasureUnitOfMeasure  \n0       [2.4, 17.9, 24.4]  Percentage of participants  \n1       [8.2, 38.1, 41.5]  Percentage of participants  \n2   [-23.6, -64.8, -65.9]              Percent change  \n3   [-19.0, -45.5, -47.9]              Percent change  \n4       [9.4, 38.6, 48.8]  Percentage of participants  "
                    },
                    "execution_count": 369,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "outcomes1 = study_1.extract_outcomes()\noutcomes1.head()"
        },
        {
            "cell_type": "code",
            "execution_count": 370,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>NCTId</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>NCT03334422</td>\n      <td>Primary</td>\n      <td>Percentage of Participants Achieving Investiga...</td>\n      <td>The IGA measures the investigator's global ass...</td>\n      <td>16 Weeks</td>\n      <td>NaN</td>\n      <td>percentage of participants</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>NCT03334422</td>\n      <td>Secondary</td>\n      <td>Percentage of Participants Achieving IGA of 0 ...</td>\n      <td>The IGA measures the investigator's global ass...</td>\n      <td>16 Weeks</td>\n      <td>NaN</td>\n      <td>percentage of participants</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>NCT03334422</td>\n      <td>Secondary</td>\n      <td>Percentage of Participants Achieving Eczema Ar...</td>\n      <td>The EASI assesses objective physician estimate...</td>\n      <td>16 Weeks</td>\n      <td>NaN</td>\n      <td>percentage of participants</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>NCT03334422</td>\n      <td>Secondary</td>\n      <td>Percentage of Participants Achieving EASI90</td>\n      <td>The EASI assesses objective physician estimate...</td>\n      <td>16 Weeks</td>\n      <td>NaN</td>\n      <td>percentage of participants</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>NCT03334422</td>\n      <td>Secondary</td>\n      <td>Percent Change From Baseline on EASI Score</td>\n      <td>The EASI assesses objective physician estimate...</td>\n      <td>Baseline, 16 Weeks</td>\n      <td>NaN</td>\n      <td>Percent Change</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "         NCTId OutcomeMeasureType  \\\n0  NCT03334422            Primary   \n1  NCT03334422          Secondary   \n2  NCT03334422          Secondary   \n3  NCT03334422          Secondary   \n4  NCT03334422          Secondary   \n\n                                 OutcomeMeasureTitle  \\\n0  Percentage of Participants Achieving Investiga...   \n1  Percentage of Participants Achieving IGA of 0 ...   \n2  Percentage of Participants Achieving Eczema Ar...   \n3        Percentage of Participants Achieving EASI90   \n4         Percent Change From Baseline on EASI Score   \n\n                           OutcomeMeasureDescription OutcomeMeasureTimeFrame  \\\n0  The IGA measures the investigator's global ass...                16 Weeks   \n1  The IGA measures the investigator's global ass...                16 Weeks   \n2  The EASI assesses objective physician estimate...                16 Weeks   \n3  The EASI assesses objective physician estimate...                16 Weeks   \n4  The EASI assesses objective physician estimate...      Baseline, 16 Weeks   \n\n  OutcomeMeasurementValue OutcomeMeasureUnitOfMeasure  \n0                     NaN  percentage of participants  \n1                     NaN  percentage of participants  \n2                     NaN  percentage of participants  \n3                     NaN  percentage of participants  \n4                     NaN              Percent Change  "
                    },
                    "execution_count": 370,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "outcomes2 = study_2.extract_outcomes()\noutcomes2.head()"
        },
        {
            "cell_type": "code",
            "execution_count": 371,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>NCTId</th>\n      <th>OutcomeMeasureType</th>\n      <th>OutcomeMeasureTitle</th>\n      <th>OutcomeMeasureDescription</th>\n      <th>OutcomeMeasureTimeFrame</th>\n      <th>OutcomeMeasurementValue</th>\n      <th>OutcomeMeasureUnitOfMeasure</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>0</th>\n      <td>NCT03131648</td>\n      <td>Primary</td>\n      <td>Subjects With Investigator's Global Assessment...</td>\n      <td>The IGA is an instrument used in clinical tria...</td>\n      <td>At Week 16</td>\n      <td>NaN</td>\n      <td>Participants</td>\n    </tr>\n    <tr>\n      <th>1</th>\n      <td>NCT03131648</td>\n      <td>Primary</td>\n      <td>Subjects Achieving at Least 75% Reduction in E...</td>\n      <td>The EASI is a validated measure used in clinic...</td>\n      <td>At Week 16</td>\n      <td>NaN</td>\n      <td>Participants</td>\n    </tr>\n    <tr>\n      <th>2</th>\n      <td>NCT03131648</td>\n      <td>Secondary</td>\n      <td>Reduction of Worst Daily Pruritus Numeric Rati...</td>\n      <td>Subjects will assess their worst itch severity...</td>\n      <td>Week 0 to Week 16</td>\n      <td>NaN</td>\n      <td>Participants</td>\n    </tr>\n    <tr>\n      <th>3</th>\n      <td>NCT03131648</td>\n      <td>Secondary</td>\n      <td>Change in Scoring Atopic Dermatitis (SCORAD) F...</td>\n      <td>The SCORAD is a validated tool to evaluate the...</td>\n      <td>Week 0 to Week 16</td>\n      <td>NaN</td>\n      <td>units on a scale</td>\n    </tr>\n    <tr>\n      <th>4</th>\n      <td>NCT03131648</td>\n      <td>Secondary</td>\n      <td>Change in Dermatology Life Quality Index (DLQI...</td>\n      <td>The Dermatology Life Quality Index (DLQI) is a...</td>\n      <td>Week 0 to Week 16</td>\n      <td>NaN</td>\n      <td>units on a scale</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "         NCTId OutcomeMeasureType  \\\n0  NCT03131648            Primary   \n1  NCT03131648            Primary   \n2  NCT03131648          Secondary   \n3  NCT03131648          Secondary   \n4  NCT03131648          Secondary   \n\n                                 OutcomeMeasureTitle  \\\n0  Subjects With Investigator's Global Assessment...   \n1  Subjects Achieving at Least 75% Reduction in E...   \n2  Reduction of Worst Daily Pruritus Numeric Rati...   \n3  Change in Scoring Atopic Dermatitis (SCORAD) F...   \n4  Change in Dermatology Life Quality Index (DLQI...   \n\n                           OutcomeMeasureDescription OutcomeMeasureTimeFrame  \\\n0  The IGA is an instrument used in clinical tria...              At Week 16   \n1  The EASI is a validated measure used in clinic...              At Week 16   \n2  Subjects will assess their worst itch severity...       Week 0 to Week 16   \n3  The SCORAD is a validated tool to evaluate the...       Week 0 to Week 16   \n4  The Dermatology Life Quality Index (DLQI) is a...       Week 0 to Week 16   \n\n  OutcomeMeasurementValue OutcomeMeasureUnitOfMeasure  \n0                     NaN                Participants  \n1                     NaN                Participants  \n2                     NaN                Participants  \n3                     NaN            units on a scale  \n4                     NaN            units on a scale  "
                    },
                    "execution_count": 371,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "outcomes3 = study_3.extract_outcomes()\noutcomes3.head()"
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "It looks like all my outcomes are being extracted as expected.  In the next version of this notebook I will aggregate the various endpoints used in the clinical trial group returned from the query for the purposes of comparing endpoints across trials and in the aggregate."
        },
        {
            "cell_type": "markdown",
            "metadata": {},
            "source": "Below is an illustrative example of one type of analysis I will be able to perform in the next iteration of this notebook."
        },
        {
            "cell_type": "code",
            "execution_count": 372,
            "metadata": {},
            "outputs": [],
            "source": "outcome_tracker = {}\n\ndef outcome_track(outcome_list, track_dict):  # df_initial['OutcomeMeasureTitle'][0]  runs on a single column entry (1 study)\n    \n    for outcome in outcome_list:\n        if outcome in track_dict.keys():\n            track_dict[outcome] += 1\n        else:\n            track_dict[outcome] = 1\n\nfor study_outcome in ad_phase_3['OutcomeMeasureTitle']:\n    outcome_track(study_outcome, outcome_tracker)"
        },
        {
            "cell_type": "code",
            "execution_count": 376,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/html": "<div>\n<style scoped>\n    .dataframe tbody tr th:only-of-type {\n        vertical-align: middle;\n    }\n\n    .dataframe tbody tr th {\n        vertical-align: top;\n    }\n\n    .dataframe thead th {\n        text-align: right;\n    }\n</style>\n<table border=\"1\" class=\"dataframe\">\n  <thead>\n    <tr style=\"text-align: right;\">\n      <th></th>\n      <th>index</th>\n      <th>Frequency</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <th>23</th>\n      <td>Percentage of Participants Achieving EASI90</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>25</th>\n      <td>Percentage of Participants Achieving SCORing A...</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>43</th>\n      <td>Percentage of Participants Achieving Investiga...</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>40</th>\n      <td>Change From Baseline on the Work Productivity ...</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>36</th>\n      <td>Change From Baseline in the Total Score of the...</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>35</th>\n      <td>Percent Change From Baseline in Itch NRS</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>34</th>\n      <td>Percentage of Participants Developing Skin Inf...</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>33</th>\n      <td>Change From Baseline in Body Surface Area (BSA...</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>32</th>\n      <td>Percentage of Participants Achieving SCORAD90</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>31</th>\n      <td>Change From Baseline in SCORAD</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>30</th>\n      <td>Percentage of Participants Achieving IGA of 0</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>27</th>\n      <td>Change From Baseline in the Score of Item 2 of...</td>\n      <td>5</td>\n    </tr>\n    <tr>\n      <th>37</th>\n      <td>Change From Baseline in the Patient Global Imp...</td>\n      <td>4</td>\n    </tr>\n    <tr>\n      <th>29</th>\n      <td>Percentage of Participants Achieving EASI50</td>\n      <td>4</td>\n    </tr>\n    <tr>\n      <th>28</th>\n      <td>Change From Baseline in Skin Pain NRS</td>\n      <td>4</td>\n    </tr>\n    <tr>\n      <th>26</th>\n      <td>Percentage of Participants Achieving a 4-Point...</td>\n      <td>4</td>\n    </tr>\n    <tr>\n      <th>42</th>\n      <td>Change From Baseline on the European Quality o...</td>\n      <td>4</td>\n    </tr>\n    <tr>\n      <th>46</th>\n      <td>Percent Change From Baseline in EASI Score</td>\n      <td>4</td>\n    </tr>\n    <tr>\n      <th>68</th>\n      <td>Percent Change From Baseline in Eczema Area an...</td>\n      <td>3</td>\n    </tr>\n    <tr>\n      <th>39</th>\n      <td>Change From Baseline on the Dermatology Life Q...</td>\n      <td>3</td>\n    </tr>\n  </tbody>\n</table>\n</div>",
                        "text/plain": "                                                index  Frequency\n23        Percentage of Participants Achieving EASI90          5\n25  Percentage of Participants Achieving SCORing A...          5\n43  Percentage of Participants Achieving Investiga...          5\n40  Change From Baseline on the Work Productivity ...          5\n36  Change From Baseline in the Total Score of the...          5\n35           Percent Change From Baseline in Itch NRS          5\n34  Percentage of Participants Developing Skin Inf...          5\n33  Change From Baseline in Body Surface Area (BSA...          5\n32      Percentage of Participants Achieving SCORAD90          5\n31                     Change From Baseline in SCORAD          5\n30      Percentage of Participants Achieving IGA of 0          5\n27  Change From Baseline in the Score of Item 2 of...          5\n37  Change From Baseline in the Patient Global Imp...          4\n29        Percentage of Participants Achieving EASI50          4\n28              Change From Baseline in Skin Pain NRS          4\n26  Percentage of Participants Achieving a 4-Point...          4\n42  Change From Baseline on the European Quality o...          4\n46         Percent Change From Baseline in EASI Score          4\n68  Percent Change From Baseline in Eczema Area an...          3\n39  Change From Baseline on the Dermatology Life Q...          3"
                    },
                    "execution_count": 376,
                    "metadata": {},
                    "output_type": "execute_result"
                }
            ],
            "source": "outcome_tracker_df = pd.Series(outcome_tracker).to_frame('Frequency').reset_index().sort_values(by='Frequency', ascending=False)\noutcome_tracker_df.head(20)"
        },
        {
            "cell_type": "code",
            "execution_count": 391,
            "metadata": {},
            "outputs": [
                {
                    "data": {
                        "text/plain": "Text(0.5, 0, 'Outcome Measure')"
                    },
                    "execution_count": 391,
                    "metadata": {},
                    "output_type": "execute_result"
                },
                {
                    "data": {
                        "image/png": "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\n",
                        "text/plain": "<Figure size 1440x432 with 1 Axes>"
                    },
                    "metadata": {
                        "needs_background": "light"
                    },
                    "output_type": "display_data"
                }
            ],
            "source": "fig = plt.figure(figsize=[20,6])\nax = sns.barplot(data=outcome_tracker_df.head(20), x='index', y='Frequency', estimator=sum, ci=None)\nfor item in ax.get_xticklabels():\n    item.set_rotation(90)\nfor p in ax.patches:\n    ax.text(x = p.get_x()+(p.get_width()/2),y = p.get_height()+0.05,s = '{}'.format(p.get_height(),ha = 'center'))\n\nax.set_title('Top 20 Most Common Primary + Secondary Outcome Measures Reported Atopic Dermatitis Clinical Trials', fontsize=18)\nax.set_xlabel('Outcome Measure')"
        }
    ],
    "metadata": {
        "kernelspec": {
            "display_name": "Python 3.7",
            "language": "python",
            "name": "python3"
        },
        "language_info": {
            "codemirror_mode": {
                "name": "ipython",
                "version": 3
            },
            "file_extension": ".py",
            "mimetype": "text/x-python",
            "name": "python",
            "nbconvert_exporter": "python",
            "pygments_lexer": "ipython3",
            "version": "3.7.10"
        },
        "metadata": {
            "interpreter": {
                "hash": "59a4d4b4478b5f20e331a2a4cc8c12e2d26aa12bbd9e314e40fe03f165a80710"
            }
        }
    },
    "nbformat": 4,
    "nbformat_minor": 5
}